Staphyloccus Aureus Bacteremia clinical trials

Explore recruiting staphyloccus aureus bacteremia clinical trials.

Also recruiting in Europe

Staphyloccus Aureus Bacteremia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Kan skattning av njurfunktion (eGFR) förutsäga vilka patienter med S. aureus-bakteremi som behöver justerad dosering via monitorering av kloxacillinkoncentrationer i plasma (TDM)?

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Staphyloccus Aureus Bacteremia trials by city

Staphyloccus Aureus Bacteremia in Toronto Staphyloccus Aureus Bacteremia in Vancouver Staphyloccus Aureus Bacteremia in Montreal Staphyloccus Aureus Bacteremia in Calgary Staphyloccus Aureus Bacteremia in Edmonton Staphyloccus Aureus Bacteremia in Ottawa Staphyloccus Aureus Bacteremia in Winnipeg Staphyloccus Aureus Bacteremia in Quebec City Staphyloccus Aureus Bacteremia in Hamilton Staphyloccus Aureus Bacteremia in Kitchener Staphyloccus Aureus Bacteremia in London Staphyloccus Aureus Bacteremia in Halifax Staphyloccus Aureus Bacteremia in New York Staphyloccus Aureus Bacteremia in Los Angeles Staphyloccus Aureus Bacteremia in Chicago Staphyloccus Aureus Bacteremia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease